Oleg Nodelman - Sep 19, 2023 Form 4/A - Amendment Insider Report for Nuvation Bio Inc. (NUVB)

Role: Director
Signature: Oleg Nodelman, individually and as Manager of EcoR1 Capital, LLC and Biotech Opportunity GP, LLC
Stock symbol: NUVB
Transactions as of: Sep 19, 2023
Transactions value $: $6,692,265
Form type: 4/A - Amendment
Date filed: 9/22/2023, 03:44 PM
Date Of Original Report: Sep 21, 2023
Previous filing: Sep 21, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUVB	Class A Common Stock	Purchase	$6.46M	+5.14M	+69.86%	$1.26	12.5M	Sep 19, 2023	See Notes	F1, F2, F3
transaction	NUVB	Class A Common Stock	Purchase	$159K	+117K	+0.94%	$1.36	12.6M	Sep 20, 2023	See Notes	F1, F2, F4
transaction	NUVB	Class A Common Stock	Purchase	$72.1K	+53K	+0.42%	$1.36	12.7M	Sep 21, 2023	See Notes	F1, F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	EcoR1 Capital, LLC ("EcoR1") is the investment adviser to EcoR1 Capital Fund, L.P. ("Capital Fund"), EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund") and EcoR1 Venture Opportunity Fund, L.P. ("Venture Fund"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC ("Biotech") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
F2	Qualified Fund is the record holder of these securities.
F3	On 9/21/2023, the reporting persons filed a Form 4 (the "Original Form 4") that inadvertently identified the date of this transaction as 2/19/2023. As reported in this amendment, the date of this transaction was 9/19/2023. The Original Form 4 also inadvertently identified the date of the earliest transaction reported in the Original Form 4 as 2/19/2023. As reported in this amendment, the date of the earliest transaction was 9/19/2023.
F4	The Original Form 4 inadvertently identified the date of this transaction as 2/20/2023. As reported in this amendment, the date of this transaction was 9/20/2023.
F5	Original Form 4 inadvertently identified the date of this transaction as 2/21/2023. As reported in this amendment, the date of this transaction was 9/21/2023.